Filgrastim biosimilar (Mycenax Biotech)

非格司亭生物类似药（Mycenax Biotech）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Mycenax Biotech)

Drug Alias NamerhG-CSF (Mycenax Biotech)非格司亭生物仿制药（Mycenax Biotech）Recombinant human granulocyte macrophage colony stimulating factor (Mycenax Biotech)重组人粒细胞刺激因子（Mycenax Biotech）GranNEX

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusNDA/BLA

Highest Status in ChinaN/A

Originator CompaniesMycenax Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesMycenax Biotech Inc

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02